I don't think there's much in that PR we didn't already know. For example, we knew a higher power device would need a new 510(k), and we knew the Synergy deal was dead. I'm disappointed in his statement that "talks with a major distributor in Asia and the CIS countries fell through after about six months of conversation" because (a) Synergy was never a major distributor and (b) six months of conversation means August - January, so they knew it was dead in February yet stuck with their "we'll release news when it's appropriate" story. But that's water under the bridge.
JNDouble1 already told us that the new KT Tape management didn't like the ActiPatch product.
One new development: Staelin's message about "actively marketing the product line" and the need for funding is refreshing. This message is different from his previous email where he implied that the company was content with the status quo of sitting back as an OEM manufacturer and allowing others to do the marketing and promotional work.
When Staelin uses the word "dissolution," that's just Safe Harbor talk. THAT won't happen, IMO, but Staelin is signaling that he's not going to single-handedly fund this company in 2024.
I've been saying for years that a R/S is inevitable. They will want to have accompanying news to prop up the share price though. Hopefully, Dr. Ilfeld will publish positive results, get more funding, and start larger studies. An R/S won't be fun, but it would be better than borrowing from sharks or toxic lenders.
Friday after market close before a holiday was a good time to release that PR. Staelin is sharp, but that's another thing we already knew.
